TY  - JOUR

T1  - 12 month results of CALIBER: A phase II randomised feasibility trial of chemoablation with MMC versus surgical management in low risk (LR) non-muscle invasive bladder cancer (NMIBC)

JO  - European Urology Supplements

UR  - https://doi.org/10.1016/s1569-9056(19)30560-3

PY  - 2019/03/01

AU  - Mostafid H

AU  - Porta N

AU  - Cresswell J

AU  - Griffiths T

AU  - Kelly J

AU  - Catto J

AU  - Davenport K

AU  - McGrath J

AU  - Cooke P

AU  - Masood S

AU  - Feber A et al

ED  - 

DO  - DOI: 10.1016/s1569-9056(19)30560-3

PB  - Elsevier BV

VL  - 18

IS  - 1

SP  - e762

EP  - e763

Y2  - 2025/11/12

ER  -